Soleno Therapeutics Inc. buy Guggenheim
Start price
07.08.25
/
50%
€69.15
Target price
07.08.26
€90.90
Performance (%)
-41.75%
Price
02.01.26
€39.94
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Soleno Therapeutics Inc. is performing very badly with a performance of -41.75%. This prediction currently runs until 07.08.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | -3.604% | -3.604% |
| iShares Core DAX® | 0.869% | 2.751% |
| iShares Nasdaq 100 | -0.852% | -2.079% |
| iShares Nikkei 225® | 0.436% | -1.741% |
| iShares S&P 500 | -0.122% | -0.584% |
Comments by Guggenheim for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Guggenheim from $97.00 to $106.00. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Stopped prediction by Guggenheim for Soleno Therapeutics Inc.
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€59.30
27.08.25
27.08.25
€91.11
27.08.26
27.08.26
-32.07%
02.01.26
02.01.26
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€67.90
08.05.25
08.05.25
€85.63
08.05.26
08.05.26
-40.68%
02.01.26
02.01.26
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€65.90
28.03.25
28.03.25
-
28.03.26
28.03.26
-38.88%
02.01.26
02.01.26
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.30
21.11.23
21.11.23
€36.55
21.11.24
21.11.24
106.38%
22.11.24
22.11.24